These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7019013)

  • 21. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH.
    Cohen H; Arachchillage DR; Middeldorp S; Beyer-Westendorf J; Abdul-Kadir R
    J Thromb Haemost; 2016 Aug; 14(8):1673-6. PubMed ID: 27346676
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood coagulation and fibrinolysis in human pregnancy.
    Bonnar J
    Bibl Anat; 1973; 12():58-63. PubMed ID: 4790392
    [No Abstract]   [Full Text] [Related]  

  • 23. Coagulation disorders.
    Bonnar J
    J Clin Pathol Suppl (R Coll Pathol); 1976; 10():35-41. PubMed ID: 1067268
    [No Abstract]   [Full Text] [Related]  

  • 24. Prenatal screening for thrombophilia: the background and the approach.
    James AH; Brancazio LR
    Gynecol Obstet Invest; 2005; 60(1):47-57. PubMed ID: 15692216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy.
    Lindqvist PG; Dahlbäck B
    Thromb Haemost; 2000 Jul; 84(1):140-1. PubMed ID: 10928487
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood coagulation disorders in pregnancy toxicosis, especially in premature placental detachment].
    MASTBOOM JL
    Ned Tijdschr Verloskd Gynaecol; 1951; 51(3-4):135-45. PubMed ID: 14890809
    [No Abstract]   [Full Text] [Related]  

  • 27. Prothrombotic genotypes and pre-eclampsia.
    Walker ID
    Thromb Haemost; 2002 May; 87(5):777-8. PubMed ID: 12038775
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of deep vein thrombosis and preeclampsia. Therapeutic possibilities].
    Palot M; Daigremont-Botmans C; Visseaux H
    Ann Med Interne (Paris); 2003; 154(5-6):354-60. PubMed ID: 15027590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Status of the hemostasis system in mild forms of late pregnancy toxemias].
    Marusov AP; Skipetrov VP; Dancheva TN
    Akush Ginekol (Mosk); 1987 Aug; (8):68-9. PubMed ID: 3688362
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebral venous thrombosis: hemorrhagic stroke requiring acute heparin anticoagulation.
    Hoffman JR
    J Emerg Med; 2006 Jul; 31(1):111; author reply 111-3. PubMed ID: 16798170
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemostatic function and coagulopathy during pregnancy.
    Bonnar J
    Obstet Gynecol Annu; 1978; 7():195-217. PubMed ID: 351483
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulation in pregnancy and neuraxial blocks.
    Kopp SL; Horlocker TT
    Anesthesiol Clin; 2008 Mar; 26(1):1-22, v. PubMed ID: 18319177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated intravascular coagulation in pregnancy.
    Smith H; Gregori CA; Breen JL
    J Med Soc N J; 1974 Oct; 71(10):729-36. PubMed ID: 4607971
    [No Abstract]   [Full Text] [Related]  

  • 34. [Physiopathology of coagulation in various obstetrical and gynecological conditions. I. Physiopathology of coagulation in pregnancy with special reference to toxic manifestations].
    FURIAN R; CENTARO A
    Monit Ostet Ginecolog; 1951; 22(5):302-15. PubMed ID: 14910477
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebral venous thrombosis: hemorrhagic stroke requiring acute heparin anticoagulation.
    Williams DT; Sue MW; Gabriel EA; Liu AK
    J Emerg Med; 2004 Oct; 27(3):295-7. PubMed ID: 15388220
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the level of endogenous heparin and various indicators of hemostasis in late pregnancy toxemias].
    Strizhova NV; Alikhanova ZM; Efimov VS
    Akush Ginekol (Mosk); 1985 Oct; (10):53-5. PubMed ID: 2935011
    [No Abstract]   [Full Text] [Related]  

  • 37. [State of the coagulation and anti-coagulation systems of parturients having had late pregnancy toxemias, and of the newborn infants].
    Vorontsov AA; Gurova IF; Franchuk AE
    Vopr Okhr Materin Det; 1972 May; 17(5):68-72. PubMed ID: 5029756
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current concepts of the pathogenetic mechanisms of late pregnancy toxemias].
    Strizhova NV
    Akush Ginekol (Mosk); 1985 May; (5):15-7. PubMed ID: 3161381
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thrombophilia in pregnancy--physiology and pathophysiology of hemocoagulation changes during normal and pathological gravidity].
    Sudrová M; Kvasnicka J; Linhartová P; Mazoch J
    Cas Lek Cesk; 2007; 146(11):853-7. PubMed ID: 18069211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring the effects and managing the side effects of anticoagulation during pregnancy.
    Gris JC; Lissalde-Lavigne G; Quére I; Marés P
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):397-411. PubMed ID: 16962917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.